ACB-FCC-SAR Test Exclusion Evaluation
Microsoft Word 2010 Microsoft Word 2010
tags: Array
(
[0] => Array
(
[url_sha] => 33c36ce04d90a43d4b5305e3403ab1232582389e8d2fd13364c71445180a8e97
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8252777
[href_text] => ACB-FCC-SAR Test Exclusion Evaluation
[href_description] => EPS Bio Technology Corp. D070 Blood Glucose Monitoring System 2AQBR-D070 2AQBRD070 d070
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] =>
[http_filename] => GetApplicationAttachment.html?id=8252777
[http_size] => 103351
[file_sha256] => 215ba16c5d3863acc9849310d2eb5df2b2077326da4c29c1afcc5107fbdc0948
[domain] => document.fccid
)
)
Array
(
[0] => Array
(
[id] => 8252777
[file_sha256] =>
[applicationId] => uBieHmEmaz0pYUARHDdn9A==
[description] => ACB-FCC-SAR Test Exclusion Evaluation
[shortTermConfidential] => No
[permanentConfidential] => No
[supercede] => No
[exhibitType] => RF Exposure Info
[fileType] => Adobe Acrobat PDF
[displayType] => pdf
[fileSize] => 103351
[submissionDate] => 2025-04-30 00:00:00
[dateAvailable] => 2025-04-30 00:00:00
[creationDate] =>
[producer] =>
[modDate] =>
[title] =>
[creator] =>
[author] =>
[pages] =>
[realSize] =>
[html] => 0
[png] => 0
[txt] => 0
[version] => 0
[source] => 0
[fccId] => 2AQBR-D070
[cleanFccId] => 2AQBRD070
[exif] => 0
)
)